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Introduction 
Many patients seen in clinical practice present with fatigue and pain-related problems either 
as a primary complaint or secondary to medical or psychiatric conditions (Fischhoff and 
Wessely 2003). These complaints are often labeled as psychosomatic or somatoform. 
However, these terms inappropriately emphasize the primacy of psychological factors or 
attributions in the causation of these disorders. They are also based on obsolete models of 
the relationship between body and mind, and often rightfully meet with resistance in patients 
(Dimsdale et al. 2013, Luyten and Van Houdenhove 2013, Luyten et al. 2013). For the same 
reason, the notion of “medically unexplained syndromes” is not really helpful for most 
patients, particularly because a wide range of biological and psychosocial factors have been 
shown to be involved in the etiology and pathophysiology of these syndromes. The 
introduction in DSM-5 of the category of somatic symptom disorder (SSD) represents a 
major leap forward in this area (Dimsdale et al. 2013), although its definition still 
emphasizes disproportionate cognition and affect of the patient with regard to his or her 
symptoms; these may in fact not always be that disproportionate as they may reflect an 
understandable response to persistent and often insufficiently understood symptoms. The 
notion of functional somatic disorders (FSDs) is often used in this context, and to good 
avail, as patients with these conditions show dysregulations of neurobiological systems and 
neural circuits involved in fatigue and pain processing, dysregulations which may become 
chronic. For clinical purposes, it may be simply preferable to refer to these patients as 
patients presenting with persistent somatic complaints that have not responded to 
treatments and/or that have been insufficiently understood. 
Patients presenting with these problems are often considered to be “difficult to treat”, 
but it is important to realize that this patient group is very heterogeneous. Furthermore, as 
we will argue in this chapter, current evidence-based treatments often do not adequately take 
into account existing knowledge concerning interpersonal and attachment issues in the 
treatment of these disorders; this is not only of psychological importance, as there is an 
intrinsic relationship between stress regulation and the attachment system. In this chapter, 
we present an integrative, broad attachment-based approach to the understanding, 
management, and treatment of these disorders.  
Recent research on stress has led to renewed attention to the importance of early 
adversity and later stress in these patients. This research has also led to a new focus on what 
clinicians often find to be the most important issue for many of these patients – their 
interpersonal problems, both in relationships with significant others and with healthcare 
professionals. Contemporary attachment theory provides a theoretical framework that not 
only helps us to understand these issues but, more importantly, also provides important 
leads with regard to management and intervention. The take-home message of this chapter is 
that contemporary attachment theory helps us to understand these patients better. This helps 
us to establish a better relationship with these patients, which in turn leads patients to better 
understand what is happening to them. This greatly increases adherence to treatment, with 
consequent effects on the course of their presenting problems and how they influence the 
patients’ lives.  
This chapter begins by outlining a broad attachment approach to these patients. We 
focus on three specific features of patients who present with persistent somatic complaints: 
(a) attachment issues; (b) problems related to (embodied) mentalizing, that is, the capacity 
to reflect on their own embodied self and others, and (c) problems with epistemic trust – the 
capacity to trust others as a source of knowledge about the world and, in particular, about 
their presenting problems. We then discuss the implications of this attachment-based 
approach for intervention, considering general management principles as well as more 
specialized treatment approaches that have evolved from a base of contemporary attachment 
approaches. 
 
Classification and diagnosis 
The disorders that can be considered to be FSDs comprise a wide variety of conditions 
affecting different body systems, which may be seen by healthcare professionals in different 
medical specialties. These conditions include, but are not limited to, chronic fatigue 
syndrome (CFS; internal medicine) and fibromyalgia (rheumatology), irritable bowel 
syndrome (IBS; gastroenterology); chronic pelvic pain (gynecology); non-cardiac chest pain 
(cardiology); tension headache (neurology); hyperventilation syndrome (respiratory 
medicine), and multiple chemical sensitivity (internal medicine) (Fischhoff and Wessely 
2003, Wessely and White 2004). There is considerable controversy regarding whether these 
disorders are indeed distinct entities or represent different presentations of a common 
functional somatic syndrome, and whether they are caused purely by biological factors or by 
a combination of biological and psychological factors. These debates, which are based more 
on ideological than scientific arguments, have done little to improve our knowledge of the 
etiology, course and treatment of the FSDs.  
While the disorders listed above have different characteristic presentations, there is 
considerable evidence to suggest that the FSDs are not individual isolated disorders. There 
is both high comorbidity among these disorders and high familial coaggregation (i.e., it is 
relatively common to find members of the same family showing symptoms of the same or 
different FSDs) (Aggarwal et al. 2006, Anda et al. 2006). In addition, the high comorbidity 
between FSDs and affective disorders such as depression and anxiety (Arnold et al. 2006, 
Pae et al. 2008) has led to the suggestion that the FSDs are also part of a spectrum of 
affective disorders (Hudson et al. 2004, Hudson et al. 2003, Hudson and Pope 1996).  
Taken together, FSDs are highly prevalent. The prevalence of FSDs in the general 
population is estimated to be 4%, and up to 9% of patients in tertiary care present with more 
than one FSD (Bass and May 2002). For individual disorders, estimates of prevalence range 
between 0.5 and 2.5% for CFS (Afari and Buchwald 2003, Reeves et al. 2007), 
approximately 5% for fibromyalgia (Branco 2008, Lawrence et al. 2008, Spaeth 2009), and 
as high as 11.2% for IBS (Lovell and Ford 2012). The true prevalence of the FSDs remains 
unknown, as they are diagnosed on the basis of consensus diagnostic categories. However, 
the medical, economic and psychosocial costs associated with these disorders are known to 
be significant (Afari and Buchwald 2003, Annemans et al. 2009, Annemans et al. 2008, 
Sicras et al. 2009, Spaeth 2009). 
Current evidence-based treatments for FSDs lead to improvements in core symptoms 
and general functioning (Hauser et al. 2009, Malouff et al. 2008, NICE 2007, van Koulil et 
al. 2007). However, treatment has only limited benefit in a relatively large number of 
patients, particularly in those whose symptoms are most severe (Luyten et al. 2009, Van 
Houdenhove and Luyten 2007, Van Houdenhove and Luyten 2008). We consider that an 
attachment-based approach to the management and treatment of these patients may be most 
helpful as it offers a comprehensive approach that takes into account the biological, 
psychological and social/contextual factors that have been implicated in the development 
and course of these disorders. 
 
A contemporary attachment-based approach to FSD 
Introduction 
There is now good evidence to suggest that FSDs are associated with often severe stress 
dysregulation as a result of complex interactions between genetic and environmental factors 
(Ablin et al. 2012, Heim et al. 2009, Tak and Rosmalen 2010). This leads to a state of 
allostatic load (McEwen 2007), which disrupts the dynamic equilibrium that normally 
characterizes stress regulation systems and related neurobiological systems such as the 
immune and pain-regulating systems. This is expressed in dysfunctions of the 
hypothalamic–pituitary–adrenal (HPA) axis – the main stress regulation system – that are 
typically associated with FSDs (Heim et al. 2009, Powell et al. 2013, Tak and Rosmalen 
2010, Van Houdenhove et al. 2013). Immune system dysfunctions are often apparent as 
abnormal inflammatory activity. Proinflammatory cytokines have been shown to play a role 
in feelings of lethargy, increased stress and pain sensitivity, mild fever and cognitive 
problems (e.g. loss of concentration) – the so-called “sickness response” that is typically 
observed in many FSD patients (Dantzer et al. 2008, Watkins and Maier 2005). 
The disturbance of allostasis and accompanying biological and subjective responses 
represent a serious burden to the individual and his/her relationships, particularly as their 
complaints are often met with suspicion or disbelief by others, including health 
professionals. The individual’s experience of the physical and psychological symptoms of 
FSD and the associated distress activate his/her attachment system; this is a biologically pre-
wired system that has a key role in the regulation of stress and affect and the restoration of 
allostasis. Activation of the attachment system involves seeking proximity to attachment 
figures, which, when achieved successfully, typically leads to effective downregulation (see 
Figure 1). However, in the context of FSD, in which the complaint may be persistent and 
often lacking a clear explanation of cause of prospect of cure, the normal process of co-
regulation of stress and arousal in attachment relationships easily spirals out of control. This 
breakdown is often further reinforced by the inability of health professionals to provide 
relief, particularly when these professionals respond insufficiently to the emotional needs 
and needs for validation in particular of patients with these complaints. 
As a result, these patients have to resort to excessive use of so-called secondary 
attachment strategies, that is, stress or affect regulation strategies that are used when 
normative stress regulation fails. These strategies involve hyperactivation or deactivation of 
the attachment system (or a combination of both) in response to stress. As we will explain in 
more detail below, these strategies lead to further stress dysregulation because, as well as 
their high associated metabolic costs, they are associated with impairments in mentalizing – 
the capacity to interpret the self and others in terms of intentional mental states (i.e., 
feelings, wishes, desires, goals, etc.) – with consequent interpersonal costs, as these 
strategies give rise to (interpersonal) behaviors that perpetuate complaints.  
The end result, particularly in patients whose symptoms have become chronic, is a 
severe state of stress dysregulation and allostatic load, high symptomatic distress, serious 
impairment in mentalizing capacities, and considerable interpersonal problems (see Figure 
2). Repeated experiences of invalidation also lead to a state of epistemic distrust, 
characterized by an almost complete distrust of the medical profession, which may explain 
the “difficult to treat” character of many of these patients. As we will argue, however, these 
patients are not so much “difficult to treat” as “difficult to reach” because of their repeated 
experiences of invalidation. Hence, their distrust of health professionals reflects an 
understandable strategy, rather than a deficit or unwillingness to be treated or to be open to 
other perspectives. 
Importantly, these patients’ attachment and mentalizing problems were not 
necessarily present premorbidly, but may often be a result of persistent somatic complaints 
and continuing allostatic load. Of course, some patients with FSDs do have attachment and 
mentalizing problems before the onset of their FSD; for these patients, their symptoms and 
complaints and repeated experiences of invalidation further exacerbate these problems, 
often posing considerable challenges for management and intervention. In what follows, we 
discuss issues regarding attachment, (embodied) mentalizing and epistemic distrust in 
relation to FSDs. 
 
Attachment and FSD 
Research in humans and animals has amply demonstrated the key role that secure 
attachment experiences play in the development and regulation of the stress system. The 
attachment system has direct effects on both the subjective and neurobiological stress 
response (Gunnar and Quevedo 2007). These findings are of central importance for FSDs 
because, as we describe above, stress dysregulation is a common feature of these disorders.  
Attachment theory allows a deeper understanding of these patients’ responses when 
faced with stress and affect dysregulation. Increasing distress may activate different 
strategies in the individual in attempt to deal with this dysregulation, depending on the 
individual’s attachment history. 
An individual with a secure attachment strategy typically seeks proximity to 
attachment figures (either real or internalized), which results in downregulation of stress. 
Stress regulation thus always involves the co-regulation of stress in relation to attachment 
figures (Diamond et al. 2003, Luyten et al. 2010, Sbarra and Hazan 2008). This process has 
a strong neurobiological basis, involving, for instance, the neuropeptide oxytocin, which is 
known to have a key role in fostering attachment and regulating stress (Fonagy and Luyten 
2009, Neumann 2008). Activation of the attachment system leads to (a) activation of a 
mesocorticolimbic, dopaminergic “reward” system (Insel and Young 2001), (b) 
downregulation of neuroendocrine stress regulation systems (the HPA axis and sympathetic 
nervous system), and (c) activation of neural systems that have been found to be involved in 
mentalization (Fonagy and Luyten 2009, Lieberman 2007). These include the lateral and 
medial prefrontal cortex, lateral parietal cortex, medial parietal cortex, medial temporal 
lobe, and rostral anterior cingulate cortex. 
High mentalizing capacity, particularly when an individual is under high levels of 
stress, has been associated with resilience (Fonagy et al. 1994). This association seems to 
operate through so-called “broaden and build” (Fredrickson 2001) cycles of attachment 
security, in which feelings of secure attachment and agency, and effective stress and affect 
regulation (“build”) “pull” the individual into more adaptive environments (“broaden”), 
further fostering feelings of agency, trust, and security (Hauser et al. 2006, Mikulincer and 
Shaver 2007). In summary, secure attachment experiences, through their (neurobiologically) 
rewarding nature, reinforce affiliative behavior and mentalizing, and so foster the ability to 
regulate stress.  
However, when an individual is faced with ongoing distress – as is typical in patients 
with persistent somatic complaints – even secure attachment strategies will eventually tend 
to fail, leading to the excessive use of secondary attachment strategies in an attempt to 
downregulate stress and arousal. There is good evidence to suggest that at least a subgroup 
of patients with FSD has a history of insecure and often severely disrupted attachment 
(Afari et al. 2014, Borsini et al. 2014, Kempke et al. 2013, Luyten et al. 2006, Maunder and 
Hunter 2008, Waller and Scheidt 2006). Early adversity has been shown to be associated 
with greater vulnerability to stress-related symptoms in both animals (Champagne and 
Curley 2009, Neumann 2008) and humans (Bakermans-Kranenburg et al. 2008, Gunnar and 
Quevedo 2007). However, as noted earlier, not all patients with FSDs have a history of 
insecure attachment experiences or early adversity that might be responsible for premorbid 
mentalizing impairments. Rather, many patients’ overreliance on secondary attachment 
strategies, and their impairments in mentalizing, may be a consequence of the disorder; for 
other patients, existing problems with attachment and mentalizing may be exacerbated by 
the experience of FSD. This has important implications for the treatment of these 
individuals (Luyten et al. 2012b, Luyten and Van Houdenhove 2013). 
Clinical experience and research findings suggest that, in an attempt to cope with 
their distress, some patients begin to rely excessively on attachment deactivation strategies. 
These patients will often completely deny any attachment needs and will assert their 
autonomy and attempt to demonstrate independence and strength (Cassidy and Kobak 1988, 
Mikulincer and Shaver 2007). However, while these individuals may appear to be 
independent and resilient, this is a cover for their vulnerability (Van Houdenhove and 
Luyten 2008). Studies suggest that the use of attachment deactivation strategies is often 
found in individuals who also show high levels of self-critical perfectionism and associated 
features such as persistence, overactivity, and so-called “all-or-nothing” behavior (Creed 
2007, Luyten et al. 2011). These features reflect defensive attempts to affirm the self and 
soothe negative introjects. There is increasing evidence to suggest that these features are 
also related to FSD in a subset of patients (Luyten et al. 2011).  
The tendency to use attachment deactivating strategies is associated with 
considerable interpersonal and metabolic costs in the long term. These strategies – in 
particular, those associated with high levels of self-critical perfectionism – have been shown 
to lead to increasing isolation and loneliness (Mikulincer and Shaver 2007), while 
suppression of distress is associated with increasing allostatic load, which eventually results 
hypoactivity of the HPA axis as a consequence of the “wear and tear” of chronic stress 
(Hill-Soderlund et al. 2008, Miller et al. 2007, Wirtz et al. 2008), and impaired immune 
system function (Gouin et al. 2009). In addition, under increasing stress, attachment 
deactivating strategies tend to progressively fail, resulting in heightened feelings of stress 
and insecurity (Mikulincer et al. 2004). 
In some patients, particularly those with a history of serious early adversity and/or 
those who show features of dependent or borderline personality disorder comorbid with 
their FSD, attachment hyperactivating strategies are predominant. These strategies manifest 
as anxious efforts to find support and relief from an attachment figure, often through 
demanding, clinging, and claiming behavior (Waller and Scheidt 2006). As for deactivating 
strategies, attachment hyperactivating strategies are associated with high interpersonal and 
metabolic costs. Demanding behavior often leads to frustration and antipathy in others, 
which confirms the individual’s worst fear of being misunderstood and rejected. This 
pattern is not restricted only to close attachment figures: the patient’s relationships with 
(mental) health professionals tend to show a similar pattern. As a consequence, the “broaden 
and build cycles” that would promote resilience and feelings of security are inhibited. There 
is no effective downregulation of distress, and allostatic load increases (McEwen 2007). 
This leads to a vicious cycle, as these patients tend to respond to increased stress and 
anxiety with even greater reliance on attachment hyperactivating strategies in an attempt to 
find relief, support, and understanding from others (Maunder and Hunter 2008, Maunder et 
al. 2006). 
 
Embodied mentalizing and FSD 
Attachment issues provide only a partial explanation of the presenting symptoms and 
complaints of patients with FSDs. 
The symptoms of the disorder, and the resulting excessive use of secondary 
attachment strategies, in patients with FSD also have a negative effect on patients’ 
mentalizing abilities. This leads to the (re)-emergence of non-mentalizing modes (see 
Fonagy, 1998) that in turn lead to behaviours that further perpetuate symptoms and 
exacerbate problems in interpersonal relationships (see Figure 2). As we noted earlier in this 
chapter, mentalizing impairments are often a consequence of FSD or are exacerbated by the 
distress and interpersonal problems associated with the disorder.  
Indeed, FSD symptoms can be perceived as an “attack” from within on the 
individual’s capacity to reflect, particularly on the individual’s capacity to see the body as a 
“lived body” that he/she owns, a body that is the seat of his/her relationships with others. 
For instance, Driver (2005) described the “otherness of the illness” in patients with CFS, in 
whom this “otherness” led to regressive fears and fantasies. (Schattner et al. 2008) reported 
that it is common for patients with a chronic illness to treat the illness as an “internal object” 
that the patient perceives as a constant threat that needs to be negotiated with and soothed. 
As we described earlier, chronic somatic complaints increase stress, which further impairs 
and/or exacerbates impairments in (embodied) mentalizing. This is consistent with studies 
showing an inverse relationship between stress and mentalizing (Fonagy and Luyten 2009, 
Luyten et al. 2012a).  
Earlier formulations focused on these patients’ high levels of alexithymia (that is, 
problems with being aware of and describing emotions) (Pedrosa Gil et al. 2008a, Pedrosa 
Gil et al. 2008b, Subic-Wrana et al. 2010). However, evidence suggests that only a fairly 
small proportion of patients with FSD (15–22%) show clinically elevated levels of 
alexithymia and lack of emotional awareness (Pedrosa Gil et al. 2008a, Pedrosa Gil et al. 
2008b, Waller and Scheidt 2006). Furthermore, these features are not specific to FSD, but 
appear to reflect the effects of trauma and emotional neglect experienced by these 
individuals in early life. Hence, although patients with these issues are often seen in tertiary 
care, their premorbid deficits in mentalizing cannot be generalized to the all patients with 
FSD. However, it is important not to underestimate the impact of FSD (and negative 
responses to the patient by their close relationships and health professionals) on mentalizing, 
as many of these patients are caught up in vicious interpersonal cycles for many years, often 
compounded by issues such as loss of the ability to work. 
The mentalization-based approach that we propose suggests that, rather than being 
generally “alexithymic”, patients with FSDs often have impairments in (embodied) 
mentalizing that are much more specific – that is, they are related to specific experiences 
and symptoms. Furthermore, these impairments are related to (interpersonal) situations and 
symptoms that result in high arousal or stress (Luyten et al. 2012c).  
Clinical experience and research have shown that many of these patients 
interchangeably exhibit excessive mentalizing (hypermentalizing), expressed in apparently 
highly sophisticated narratives that lack any grounding in subjective experience, as well as 
hypomentalizing – that is, almost complete denial of the importance of inner mental states. 
In addition, many of these patients are unable to link their own emotional states to their own 
body, rather than showing a general “global” impairment in emotional awareness 
(Oldershaw et al. 2011, Stonnington et al. 2013, Subic-Wrana et al. 2010). Studies have 
suggested that patients with FSDs are less likely to describe physical sensations in terms of 
negative emotional states (Dendy et al. 2001); they are also less interoceptively accurate, 
particularly in contexts related to physical symptoms (Bogaerts et al. 2008, Bogaerts et al. 
2010). Patients with FSDs also tend to have negative beliefs about their own emotions, in 
particular, regarding the expression of emotions (Hambrook et al. 2011). Furthermore, they 
tend to show a strong need to control thoughts and feelings (Maher-Edwards et al. in press, 
Rimes and Chalder 2010) rather than exhibiting “deficits” in processing emotions.  
Context-specific impairments in (embodied) mentalizing lead to the reemergence of 
three so-called non-mentalizing modes that perpetuate the patient’s symptoms and 
interpersonal problems (see Box 1).  
In the psychic equivalence mode, patients equate inner and outer reality. Because of 
this, what is thought or felt is experienced as completely real, and there is no possibility of 
an alternative interpretation. In patients with FSD, this mode is often accompanied by a lack 
of ability or desire to explore inner mental states. This is particularly the case in patients 
who primarily use attachment deactivating strategies, and this may also explain these 
patients’ difficulties in accepting help and believing that health professionals are genuinely 
concerned about them. In psychic equivalence mode, psychological and physical pain, and 
emotional and physical exhaustion, are equated, so that, for example, psychological pain 
may be experienced as bodily pain. This may help to explain the high comorbidity that has 
been reported to exist between pain, fatigue, and depression (Hudson et al. 2004, Van 
Houdenhove and Luyten 2008). This mode also underlies patients’ resistance toward 
acknowledging the role of psychological factors in their disorder (“I am exhausted, not 
depressed”). One consequence of this mode is helplessness, which often arises in 
combination with catastrophizing (“I think there is something terribly wrong with me, so 
there is something terribly wrong with me [psychic equivalence], but no one pays attention 
[feeling of invalidation], I must have a terrible, incurable disease [catastrophizing]”). 
Psychic equivalence also has a negative influence on relationships: to the patient, thinking 
that others do not care means that they actually do not care. Being rejected hurts 
(Eisenberger et al. 2003), but for patients in the psychic equivalence mode often only the 
physical pain they feel in association with rejection seems to be real.  
Finally, and importantly, in psychic equivalence mode, the patient’s body starts to 
feel like an “alien self-part”. The body is no longer felt like “me”, it is increasingly seen and 
felt as a dysfunctioning set of organs and systems. The patient feels under constant pressure 
to externalize these alien self-parts in a defensive attempt to remove painful feelings of 
helplessness and disintegration in an attempt to restore the coherence of the self. We are all 
familiar with this tendency to evacuate self-states when we can no longer bear them (e.g., 
when we are ill) – by complaining to others, by becoming overcritical and hypersensitive to 
even minor noises, for instance. The consequence is that others are made to feel what we 
feel; yet, when extreme, this often has a destructive influence on the patient’s relationships, 
including relationships with health professionals. 
In a teleological mode, the patient recognizes that mental states drive behavior, but 
this understanding is limited to those mental states that have clearly observable causes (i.e., 
observable activities that reflect rational, goal-directed behaviors and/or material causes). 
Many patients with FSD believe that only rational, goal-directed behaviours and actions can 
be effective; this belief underlies their tendency to be excessively concerned with finding 
objective “proof” that their illness exists. When dealing with a patient in a teleological 
mode, health professionals may be drawn into endless discussions about the roles of 
biological versus psychosocial factors as the cause of the patient’s FSD.  
This tendency for patients to ruminate about the causes of their disorder often leads 
to hypermentalizing – or “mentalization on the loose” – in an extreme pretend mode. In this 
mode of experiencing subjectivity, the relationship between thoughts and feelings and 
reality is typically severed. Overly analytical, cognitive and repetitive narratives follow that 
lack any grounding in real affective experiences. The patient also typically is unable to 
switch perspectives, and attempts to switch his/her perspective are often met with fierce 
resistance (“I don’t see why I should think about what he wants, I am the one who is ill!”).  
 
Epistemic distrust and FSD 
Patients with FSD are often considered to be “difficult to treat” (Fischhoff and Wessely 
2003). We believe that this label is neither accurate nor helpful. Many patients with FSD 
feel severely misunderstood and stigmatized, and for good reason. In the face of their own 
continuing distress, for which they can find little or no relief, they are often met with 
disbelief and scepticism from others. Their feelings of stigma and not being understood are 
often reinforced by mental health professionals’ use of unhelpful diagnostic labels, obsolete 
theories about the cause of FSDs that imply a mind–body dualism, and provision of a 
pessimistic prognosis (Rudich et al. 2010, Rudich et al. 2008). Furthermore, many health 
professionals underestimate these patients’ need for validation that their problems are both 
distressing and real. This further fosters the feelings of invalidation and embitterment that 
have been demonstrated in patients with FSDs (Blom et al. 2012, Kool et al. 2009).  
Not surprisingly, these patients frequently have turbulent relationships with the 
health professionals treating them. The patient may cling on to a medical specialist, whom 
they idealize and believe to be a “last resort” who will cure them. Often, of course, this 
rapidly leads to disappointment on the part of the patient and reproach. This, in turn, tends 
to induce feelings of contempt and rejection in the professionals treating the patient; even if 
these feelings are not communicated explicitly, they can be demonstrated non-verbally, for 
example, through facial expressions of affect (Rasting et al. 2005)! These negative 
interaction patterns are likely to reduce the patient’s response to treatment, particularly if the 
dynamics between patient and health professional are not appropriately addressed.  
We believe that many iatrogenic effects of treatment in these patients are due to the 
dynamics outlined above (Luyten and Abbass 2013). We therefore believe it is crucially 
important for the management and treatment of patients with FSDs to understand that these 
patients often suffer from severe problems with epistemic trust. These problems may have 
been premorbidly present, originating from disrupted attachment experiences, and/or may 
arise from or be reinforced by negative relational experiences, including experiences in 
relationships with health professionals (Luyten et al. in press).  
“Epistemic trust” is, in essence, the capacity to trust others as a reliable source of 
knowledge about the world. This capacity first develops in young children in the context of 
their relationships with attachment figures. Individuals who experienced attachment 
disruptions in early life often have problems not just with trusting others on an emotional 
level, but also with epistemic trust. These dificulties with epistemic trust may, when severe, 
be expressed in cycles, from being overtrustful of others to complete epistemic distrust, 
expressed in epistemic hypervigilance. The individual is constantly on his/her guard: “Can I 
trust the advice or opinion of others?” Epistemic distrust is particularly prevalent among 
individuals with dismissive and disorganized attachment styles; these attachment styles are 
commonly found in patients with FSDs, as we have outlined above (Waller and Scheidt 
2006). Epistemic distrust impairs patients’ capacity to form a therapeutic alliance with 
health professionals, and to accept help from others more generally. It may also explain the 
attitude of some of these patients towards health professionals, which can verge on paranoia.  
Another facet of this distrust is patients’ tendency to ruminate on what they 
experience as others’ unwillingness to believe that they are actually ill (Van Houdenhove 
and Luyten 2008). Studies have shown this tendency to be related to these patients’ feelings 
of invalidation, loneliness and sometimes embitterment (Kool et al. 2009). Thinking in 
psychic equivalence mode, “I feel as if nobody cares about me and my illness, therefore 
nobody does care”, only tends to reinforce these feelings, and this often escalates to distrust 
in the medical profession and even to beliefs that, as well as not wanting to help, medical 
professionals want to harm the patient. Restoring epistemic trust through validation and 
communicating understanding is therefore a prerequisite for any treatment of these patients. 
 
Management and treatment 
Management of patients with FSDs needs to take into account three core features of these 
patients from an attachment perspective: (a) their overreliance on secondary attachment 
strategies, (b) their mentalizing problems, and (c) their difficulties with epistemic trust. 
These three features, particularly when excessively present, may seriously impede the 
patient’s ability to form a working relationship, and thus is likely to reduce the benefit of 
any treatment.  
A clinical approach that validates these patients’ suffering may counter their 
epistemic distrust and recover their capacity to mentalize. This will open up patients’ 
capacity to consider alternative perspectives regarding their complaints and their own 
developmental history and future. These are necessary prerequisites for any treatment to be 
successful. This is often a slow process that requires considerable empathy and tolerance of 
negative affect on the part of the clinician.  
It is particularly important for clinicians to be constantly aware of the potential for 
their interventions to be iatrogenic, given how common it is for these patients to use 
secondary attachment strategies/non-mentalizing modes either as a cause or a consequence 
of their symptoms. This frequently leads to high rates of drop-out and/or stormy 
transference and countertransference issues that are difficult to resolve even in long-term 
treatment (e.g., idealization-denigration cycles, regressive dependency, sadomasochistic 
transferences, etc.) (Luyten and Abbass 2013).  
Interventions based on these and related assumptions have been shown to be 
effective in the treatment of these patients. A meta-analysis by Abbass et al. (2009) of 23 
studies of short-term psychodynamic psychotherapy for people with FSDs (13 randomized 
controlled trials and 10 case series with pre–post outcome assessment) reported significant 
effects for physical symptoms, psychiatric symptoms, and social adjustment; these effects 
were maintained at long-term follow-up. Brief dynamic treatment was found to be 
associated with a 54% greater treatment retention rate compared to control treatments; this 
suggests that this type of treatment can address many of the interpersonal issues that render 
these patients “difficult to reach” and treat successfully. Notably, even very brief treatments 
were associated with considerable improvement. Recent research evidence also suggests 
that psychodynamic treatments influence the neurobiological circuits involved in stress, 
affect regulation, and mentalizing (Abbass et al. in press), congruent with the views 
advanced earlier in this chapter.  
For patients whose FSD is more severe, longer-term, multi-component interventions 
may be indicated. Recently, Koelen et al. (2014) published a meta-analysis of 10 
randomized controlled trials and six non-randomized trials, with a total of 890 patients 
receiving psychotherapy and 548 patients receiving treatment as usual (TAU). They 
reported that multi-component treatment was more effective than TAU for physical 
symptoms (d = 0.80 vs. 0.31, p < .05) and functional impairment (d = 0.45 vs. 0.15, p < .01), 
but not for psychological symptoms (d = 0.75 vs. 0.51, p = .21). Importantly, these effects 
were maintained at long-term follow-up. 
The formulations put forward in this chapter are in line with the core tenets of more 
interpersonally oriented psychodynamic treatments for patients with FSDs, such as brief 
interpersonal psychotherapy (Guthrie et al. 1999, Sattel et al. 2012, Thomas et al. 2009) and 
dynamic interpersonal therapy (Lemma et al. 2010). These treatments focus on the here-and-
now, placing greater emphasis on current interpersonal issues and their relation to the 
patient’s presenting symptoms rather than the patient’s history, and focusing on the process 
of reflecting on the connections between interpersonal problems and symptoms. In DIT in 
particular, the focus is often more on the process of mentalizing than the content, as 
focusing on content (e.g., the connection between the patient’s presenting symptoms and 
interpersonal issues he/she has experienced, whether in the present or the past) often 
exceeds these patients’ mentalizing abilities, particularly in the early stages of treatment and 
in patients with chronic or multiple FSDs. 
 
Conclusions 
This chapter presents a contemporary attachment-based approach to the conceptualization 
and management of patients with persistent somatic complaints. The central assumption of 
this chapter is that contemporary attachment approaches provide the clinician with a broad, 
evidence-based theoretical framework that helps to understand the connections between the 
patient’s presenting problems, his/her subjective responses to these complaints, and his/her 
developmental history. These formulations also have clear implications for the management 
of these patients regardless of the specific treatment approach used – for instance, the 
importance of health professionals being keenly aware of the importance of distinguishing 
between premorbid vulnerability and the patient’s response to his/her complaints, and the 
potential for iatrogenesis in treatment, given these patients’ impairments in epistemic trust 
and mentalizing. 
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 Figure 1. The relationship between the attachment and stress regulation systems 
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 Figure 2. Putative roles of attachment problems and mentalizing impairments in 
individuals with functional somatic disorders 
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Box 1. Three non-mentalizing modes in patients with functional somatic disorders, and 
their management in therapy 
 
 
 
 
Psychic equivalence mode 
 Patients equate inner (mental) reality with outer reality (“mind–world isomorphism”). Because of 
this, the internal has the same power as the external 
 Intolerance of alternative perspectives – leads to “concrete” understanding 
 Managed in therapy by the therapist avoiding being drawn into non-mentalizing discourse: 
validate the patient’s thoughts and feelings, but suggest alternative perspectives 
 
Teleological mode 
 Extreme exterior focus 
 Patients cannot accept anything other than an obvious, observable change or action as a true 
indicator of the intentions of the other 
 Managed in therapy by validation, then switch focus to how this makes the patient feel, and how 
these feelings are connected with current (interpersonal) problems 
 
Pretend mode 
 Ideas form no bridge between inner and outer reality; the patient’s mental world (thoughts and 
feelings) is decoupled from external reality 
 In extreme, may manifest as “dissociation” of thought (hypermentalizing or pseudomentalizing) 
 Managed in therapy by interrupting non-mentalizing processes and moving back (“rewinding”) to 
when the patient was mentalizing 
 
 
 
